FROEDTERT HLTH NEIGHORHOOD HOSP LLC
1. Target Overview & Investment Thesis
FROEDTERT HLTH NEIGHORHOOD HOSP LLC is a 16-bed suburban community hospital in WAUKESHA, WI with $34.1M in net patient revenue and a 18.3% operating margin. The hospital serves a payer mix of 31.3% Medicare, 2.5% Medicaid, and 66.2% commercial.
Thesis: Turnaround. Our ML models identify $2.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.3% to 25.7% (+736bps).
| Net Revenue HCRIS | $34.1M |
| Current EBITDA COMPUTED | $6.2M |
| Operating Margin COMPUTED | 18.3% |
| Occupancy HCRIS | 17.1% |
| Revenue / Bed COMPUTED | $2.1M |
| Net-to-Gross HCRIS | 27.8% |
| Distress Probability ML | 53.6% |
2. Market Context & Competitive Position
WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 18.3% places it above the state median. Among 69 size-comparable peers (8-32 beds), the median margin is 2.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (8-32), prioritizing same-state peers. 69 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| FROEDTERT HLTH NEIGHORHOOD HOS (Target) | WI | 16 | $34.1M | 18.3% |
| MERCY WALWORTH HOSPITAL | WI | 25 | $616.4M | 4.4% |
| MEMORIAL MEDICAL CENTER INC. | WI | 25 | $138.4M | 8.1% |
| MARSHFIELD MEDICAL CENTER-MINO | WI | 19 | $129.6M | -12.4% |
| MCHS-RED CEDAR | WI | 25 | $123.4M | 16.8% |
| OAK LEAF SURGICAL HOSPITAL LLC | WI | 13 | $109.8M | 34.1% |
| ST CROIX REGIONAL MEDICAL CENT | WI | 25 | $108.4M | -31.2% |
| DOOR COUNTY MEMORIAL HOSPITAL | WI | 25 | $106.2M | -2.7% |
| SOUTHWEST HEALTH CENTER | WI | 25 | $103.7M | 8.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $716K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $682K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $675K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $415K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $22K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $6.2M |
| + RCM Uplift | +$2.5M |
| Pro Forma EBITDA | $8.8M |
| Current Margin | 18.3% |
| Pro Forma Margin | 25.7% |
| WC Released (1x) | $1.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $9.6M | $66.3M | 6.90x | 47.1% |
| Base (11x exit) | 10.0x | 11.0x | $9.6M | $76.0M | 7.91x | 51.2% |
| Bull Case | 9.0x | 11.0x | $8.6M | $87.4M | 10.11x | 58.8% |
| Bull (12x exit) | 9.0x | 12.0x | $8.6M | $97.9M | 11.33x | 62.5% |
| Bear Case | 11.0x | 10.0x | $10.6M | $50.6M | 4.79x | 36.8% |
| Bear (11x exit) | 11.0x | 11.0x | $10.6M | $59.1M | 5.59x | 41.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 17.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 53.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 69 hospitals with 8-32 beds
- Same-state prioritization (n=70)
- Comp margins: P25=-3.6% / P50=2.8% / P75=8.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.